| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.108.814640 |
| P698 | PubMed publication ID | 19933949 |
| P50 | author | Gregg W Stone | Q90754539 |
| Bernard J Gersh | Q100694590 | ||
| P2093 | author name string | David R Holmes | |
| Abhiram Prasad | |||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reperfusion injury | Q1413991 |
| microvessel | Q6840468 | ||
| P304 | page(s) | 2105-2112 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion | |
| P478 | volume | 120 |
| Q22241919 | 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
| Q43004985 | A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage. |
| Q47140015 | Acute myocardial infarction: susceptibility-weighted cardiac MRI for the detection of reperfusion haemorrhage at 1.5 T. |
| Q97073537 | Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers |
| Q35287105 | Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade |
| Q35016999 | Atorvastatin ameliorates myocardial ischemia/reperfusion injury through attenuation of endoplasmic reticulum stress-induced apoptosis |
| Q42679599 | Atorvastatin protects cardiomyocytes against OGD/R‑induced apoptosis by inhibiting miR‑199a‑5p |
| Q99609329 | Balloon Deflation Strategy during Primary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Clinical Trial and Numerical Simulation-Based Analysis |
| Q54428010 | Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over study. |
| Q84691920 | Bradykinin and the Heart: Left, Right, or Both? |
| Q26824881 | Calcium-mediated cell death during myocardial reperfusion |
| Q36390251 | Calycosin‑7‑O‑β‑D‑glucoside attenuates ischemia‑reperfusion injury in vivo via activation of the PI3K/Akt pathway |
| Q33883312 | Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion |
| Q35090566 | Cardiovascular remodelling in coronary artery disease and heart failure |
| Q36650618 | Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation |
| Q92753202 | Catechin relieves hypoxia/reoxygenation-induced myocardial cell apoptosis via down-regulating lncRNA MIAT |
| Q50060663 | Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass. |
| Q36446530 | Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction |
| Q35895837 | Current situation and perspectives of clinical study in integrative medicine in china |
| Q36336983 | Distal coronary embolization following acute myocardial infarction increases early infarct size and late left ventricular wall thinning in a porcine model. |
| Q41248810 | Distribution of Systemically Administered Nanoparticles Reveals a Size-Dependent Effect Immediately following Cardiac Ischaemia-Reperfusion Injury |
| Q64883461 | Downregulation of microRNA‑199a‑5p attenuates hypoxia/reoxygenation‑induced cytotoxicity in cardiomyocytes by targeting the HIF‑1α‑GSK3β‑mPTP axis. |
| Q55417016 | Effect of Hexadecyl Azelaoyl Phosphatidylcholine on Cardiomyocyte Apoptosis in Myocardial Ischemia-Reperfusion Injury: A Hypothesis. |
| Q53701593 | Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice. |
| Q33788999 | Endothelial NOS activity and myocardial oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning |
| Q41848525 | Evaluation of Short- and Long-Term Efficacy of Combined Intracoronary Administration of High-Dose Adenosine and Tirofiban during Primary Percutaneous Coronary Intervention |
| Q36967326 | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) phosphorylation by protein kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury |
| Q36514177 | Hyperoxia and transforming growth factor β1 signaling in the post-ischemic mouse heart |
| Q37633996 | Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning |
| Q91700319 | Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention |
| Q54513464 | Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. |
| Q38109287 | Intravital 2-photon imaging, leukocyte trafficking, and the beating heart. |
| Q37095176 | Ionizing radiation, ion transports, and radioresistance of cancer cells |
| Q37668843 | Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists |
| Q40963907 | Ischemic postconditioning of the isolated human myocardium: Role of the applied protocol |
| Q57718773 | Lack of Benefit of Ischemic Postconditioning After Routine Thrombus Aspiration During Reperfusion |
| Q50300331 | Meta-analysis of the effects of ischemic postconditioning on structural pathology in ST-segment elevation acute myocardial infarction. |
| Q33942337 | Monocytes: protagonists of infarct inflammation and repair after myocardial infarction |
| Q46896240 | Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury |
| Q45080617 | Neutrophil TRPM2 channels are implicated in the exacerbation of myocardial ischaemia/reperfusion injury |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q30583012 | Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon |
| Q59127320 | PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation |
| Q92883594 | PLCE1 promotes myocardial ischemia-reperfusion injury in H/R H9c2 cells and I/R rats by promoting inflammation |
| Q37721711 | PTPIP51 regulates mouse cardiac ischemia/reperfusion through mediating the mitochondria-SR junction |
| Q26746998 | Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis |
| Q40633496 | Peroxisome proliferator-activated receptor γ (PPARγ) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-κB pathway |
| Q38225491 | Pharmacologic therapy for reducing myocardial infarct size in clinical trials: failed and promising approaches |
| Q64970706 | Platelet Contributions to Myocardial Ischemia/Reperfusion Injury. |
| Q38117307 | Postconditioning in patients treated with primary percutaneous coronary intervention: an updated meta-analysis |
| Q56534241 | Postconditioning promotes the cardiac repair through balancing collagen degradation and synthesis after myocardial infarction in rats |
| Q41807427 | Postconditioning with simvastatin decreases myocardial injury in rats following acute myocardial ischemia |
| Q36366202 | Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide |
| Q42091617 | Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms |
| Q44466260 | Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial |
| Q35805767 | Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway |
| Q35123172 | Rho-kinase activation in leukocytes plays a pivotal role in myocardial ischemia/reperfusion injury |
| Q37156436 | Role of endothelin in microvascular dysfunction following percutaneous coronary intervention for non-ST elevation acute coronary syndromes: a single-centre randomised controlled trial |
| Q37933583 | Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications |
| Q38263602 | ST elevation myocardial infarction: recent advances and updates. |
| Q91942070 | Slit2 Protects Hearts Against Ischemia-Reperfusion Injury by Inhibiting Inflammatory Responses and Maintaining Myofilament Contractile Properties |
| Q37636881 | Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis |
| Q47300973 | Soluble TNF-related apoptosis induced ligand (sTRAIL) is augmented by Post-Conditioning and correlates to infarct size and left ventricle dysfunction in STEMI patients: a substudy from a randomized clinical trial |
| Q34729472 | Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins. |
| Q41426748 | Symptom-to-balloon time and myocardial blush grade are predictors of left ventricular remodelling after successful primary percutaneous coronary intervention |
| Q34360180 | T-cadherin is critical for adiponectin-mediated cardioprotection in mice |
| Q26795462 | TRPM2 Channel-Mediated ROS-Sensitive Ca(2+) Signaling Mechanisms in Immune Cells |
| Q64097624 | The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury |
| Q38132746 | The neuroimmune guidance cue netrin-1: a new therapeutic target in cardiovascular disease |
| Q40573446 | The protective role of interleukin-18 binding protein in a murine model of cardiac ischemia/reperfusion injury |
| Q33934409 | Three-dimensional paper-based model for cardiac ischemia |
| Q37393468 | Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury |
| Q38542449 | Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning |
| Q41168643 | Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry |
| Q92023843 | aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model |
Search more.